Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 4, 2025 • 9:00 AM ET

Date/Time Source News Release
11/20/2024 07:00 AM EST GlobeNewswire Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement
11/15/2024 07:00 AM EST GlobeNewswire Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
08/17/2024 11:27 AM EDT GlobeNewswire UPDATE: Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
08/16/2024 07:00 AM EDT GlobeNewswire Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
07/25/2024 07:00 AM EDT GlobeNewswire Sol-Gel Announces the Signing of Six Exclusive License Agreements to Commercialize TWYNEO® and EPSOLAY® in Europe and South Africa
07/15/2024 07:00 AM EDT GlobeNewswire Sol-Gel Technologies Announces Management Realignment
05/28/2024 07:00 AM EDT GlobeNewswire Sol-Gel Announces Receipt of Nasdaq Minimum Price Notice
05/20/2024 07:00 AM EDT GlobeNewswire Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates
05/16/2024 06:00 AM EDT GlobeNewswire Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel
04/01/2024 07:00 AM EDT GlobeNewswire Sol-Gel's Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream
Page